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Inactivation of mediator complex 
protein 22 in podocytes results 
in intracellular vacuole formation, 
podocyte loss and premature death
Patricia Q. Rodriguez1, David Unnersjö‑Jess2, Sonia S. Zambrano1, Jing Guo3,4, 
Katja Möller‑Hackbarth1, Hans Blom2, Timo Jahnukainen5, Lwaki Ebarasi1 & 
Jaakko Patrakka1*
Podocytes are critical for the maintenance of kidney ultrafiltration barrier and play a key role in the 
progression of glomerular diseases. Although mediator complex proteins have been shown to be 
important for many physiological and pathological processes, their role in kidney tissue has not been 
studied. In this study, we identified a mediator complex protein 22 (Med22) as a renal podocyte cell‑
enriched molecule. Podocyte‑specific Med22 knockout mouse showed that Med22 was not needed for 
normal podocyte maturation. However, it was critical for the maintenance of podocyte health as the 
mice developed progressive glomerular disease and died due to renal failure. Detailed morphological 
analyses showed that Med22‑deficiency in podocytes resulted in intracellular vacuole formation 
followed by podocyte loss. Moreover, Med22‑deficiency in younger mice promoted the progression 
of glomerular disease, suggesting Med22‑mediated processes may have a role in the development 
of glomerulopathies. This study shows for the first time that mediator complex has a critical role in 
kidney physiology.
Renal podocyte cells are terminally differentiated epithelial cells of the glomerulus in where they form the final 
ultrafiltration barrier of the  kidney1. Podocytes are morphologically divided into three compartments: cell bodies, 
major and foot  processes2. Large cell bodies are located in the urinary space from which they extend large cellular 
protrusion, major processes, towards glomerular capillaries. Close to the capillary wall, the cellular extensions 
divide to finely interdigitating foot processes that wrap around capillaries. The foot processes are interconnected 
by a specialized cell–cell junction called the slit diaphragm. In most glomerular diseases, the slit diaphragm and/
or foot processes of podocytes are  injured1. Morphologically, this is observed as foot process  effacement2. This 
is considered to be a key event in the development of  albuminuria2, which, on the other hand, is a cardinal sign 
of kidney disease. Foot process effacement is a reversible process mediated by actin-rich cytoskeleton of foot 
processes, and it is a common down-stream effect of various pathological  stimuli2. However, in progressive renal 
diseases, the effacement may lead to loss of  podocytes3.
Overwhelming evidence pinpoints podocytes as central players in the pathogenesis of glomerulopathies and 
chronic kidney disease (CKD)1. One of the key reasons for this is that podocytes are terminally differentiated and 
cannot  proliferate1. Studies in human diseases have shown that podocyte loss correlates with the progression rate 
of glomerular  disease4,5. Studies in mouse have validated the key pathogenic role of podocytes as overexpression 
or inactivation of genes specifically in podocytes can either aggravate or slow the development of  CKD6,7. Obvi-
ously, understanding mechanisms that govern podocyte homeostasis is of crucial importance.
The Mediator complex (MED) is a multi-protein assembly that acts as a transcriptional co-activator in all 
 eukaryotes8. The complex is composed of at least 26 subunits in mammals, and its function is to communi-
cate signals from DNA-bound transcription factors to the RNA polymerase II enzyme. Different transcription 
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factors bind to different mediator subunits and many transcription factors can simultaneously bind to  MED8. 
An important feature of MED is that its subunit composition can  vary8. Consequently, the lack of individual 
MED subunits is associated with silencing of specific transcription pathways. Studies in knockout animals have 
unravelled roles of MED subunits in cellular differentiation and studies in human genetics have linked them 
to a number of human diseases. However, to date, no studies on MED in kidney tissue have been performed.
In this study, we explored MED subunits in renal podocyte cells. We show that MED subunit 22 (Med22) 
is highly enriched in podocytes and although it is not needed for the normal development of podocytes, it is 
essential for the maintenance of glomerular homeostasis as mice lacking Med22 in podocytes develop progres-
sive renal disease and die prematurely.
Results
Human Protein Atlas suggests Med22 as a podocyte‑associated MED subunit. As the role of 
MED in kidney tissue is unknown, we analysed Human Protein Atlas (www.prote inatl as.org) to identify podo-
cyte-associated MED subunits. We found immunohistochemical data in kidney tissue for 34 MED subunits 
(Suppl. Figure  1). Med21 and Med22 showed strong glomerular staining with only low signal in tubuli. As 
Med22 mRNA seemed to give more glomerulus-specific staining (Suppl. Figure 1), we focused on Med22 in 
further studies.
Med22 is enriched in podocytes and localizes to major processes. In the kidney, the expression 
of Med22 was enriched in the glomerulus in comparison to the kidney fraction devoid of glomeruli as shown 
by qPCR human kidney tissue (Fig. 1A). The expression of podocyte-specific gene  podocin9 was analysed to 
control the purity of glomerulus fractions (Fig. 1A). In immunofluorescence of human kidney tissue a strong 
reactivity for Med22 was detected in glomeruli with clearly weaker signal in rest of kidney tissue (Fig. 1B). In 
double stainings, Med22 co-localized partially with podocyte major process marker vimentin (Fig.  1C). No 
significant overlap was detected with podocyte foot process marker nephrin, mesangial cell expressed protein 
alpha-smooth muscle actin and endothelial marker CD31 (Fig. 1C). Moreover, Med22 did not co-localize sig-
nificantly with a podocyte nucleus marker Wt1 (Suppl. Figure 2A). Taken together, Med22 staining was in the 
glomerulus detected in podocytes in which it located to major processes. The specificity of anti-Med22 anti-
body was validated by immunostaining and Western blotting of cultured podocytes transfected with full-length 
human Med22 cDNA (Suppl. Figure 2B,C).
Generation of constitutive and conditional Med22 knockout mouse lines. To analyse the role 
of Med22 in the glomerulus, we first generated a conventional knockout (KO) mouse line. A transgenic mouse 
line with a cassette containing lacZ and neomycin-resistance genes, along with FRT and LoxP sites targeting the 
exon 3 of the Med22 gene, was obtained from European Mouse Mutant Cell Repository. This line was crossed 
with ThIRES-cre mouse line that is active in  oocytes10 to generate a germ line deletion and thus a constitutive 
Med22 allele lacking exon 3 (Fig. 2A). Breeding of animals heterozygous for constitutive allele did not generate 
any homozygous mice (166 pups analysed), indicating embryonic lethality. To see whether haploinsufficiency of 
Med22 resulted in glomerular diseases, we followed heterozygous mice for up to 15 months. No abnormalities 
were detected in histological or blood/urine analysis (Suppl. Figure 3A,B). Therefore, we decided to generate a 
conditional Med22 allele.
To inactivate Med22 specifically in podocytes, we crossed the original transgenic line with a FLP-deleter 
line followed by crossing with a Nphs2-cre line (Fig. 2A)11. Genotyping for this allele amplified 580 bp product, 
whereas the wild type product was 479 bp (Fig. 2B). To validate the successful deletion of exon 3 we analyzed 
Med22 mRNA in isolated glomeruli. In controls, we amplified a single cDNA fragment spanning from exon 2 to 
exon 4 (Fig. 2C). In mice with the conditional allele, we detected a shorter variant corresponding in size to skip-
ping of exon 3 in isolated glomeruli, whereas this variant was not amplified from rest of kidney tissue (Fig. 2C). 
We confirmed the loss of exon 3 in glomerular tissue by Sanger sequencing (data not shown). As part of the 
Med22 mRNA seemed intact, we termed this mouse line as a podocyte-specific Med22 mutant line (pod-Med22) 
that can represent either a null or a hypomorphic allele.
Podocyte‑specific defect in Med22 results in vacuole formation, podocyte loss and progres‑
sive renal disease. Pod-Med22 mice were born in a normal Mendelian ratio and developed normally (data 
not shown). No albuminuria was detected by 8 weeks of age (Fig. 2D). However, the mice exhibited massive 
albuminuria by 12 weeks of age that further increased by 16 weeks of age. In line with this, animals showed 
normal blood urea nitrogen levels at 8 weeks of age but the levels were significantly increased at 16 weeks of age 
(Fig. 2D). All pod-Med22 animals (a total of 14) died by 20 weeks of age due to renal failure, whereas littermate 
control animals (a total of 64), including both wild type and heterozygote mice, showed 100% survival (Fig. 2D).
In light microscopy, 4- and 8-week old pod-Med22 kidneys showed no abnormalities (Fig. 3A, data not 
shown). At 12 weeks of age, pod-Med22 mice exhibited large “empty” vacuole-like structures in podocytes that 
were often difficult to discern from capillary lumens in light microscopy (Fig. 3B). These structures were negative 
for lipids as detected by oil red staining (data not shown). Focal segmental glomerulosclerosis, which develops 
secondary to podocyte loss, was also observed (Fig. 3B). In addition, dilated tubuli with hyaline casts, a second-
ary sign of albuminuria, were detected (Fig. 3B). At 16 weeks of age, more advanced changes were detected with 
almost global glomerulosclerosis and tubular atrophy (Fig. 3C). Semi-quantification of key histological features 
validated the abundant histological changes of pod-Med22 mice (Fig. 3D).
In electron microscopy, glomeruli appeared normal in 4-week old mice but at 8 weeks of age pod-Med22 
mice showed a significant foot process effacement (Fig. 4A). Rarely, small vacuoles in podocytes were observed 
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Figure 1.  Med22 is expressed highly by podocytes. (A) qPCR analysis of human kidney tissue shows that 
Med22 is expressed more strongly by glomerular tissue (glom) than rest of kidney fraction (rok). Podocin, a 
podocyte-specific gene, was used to control purity of glomerular fractions. (B) Immunofluorescence staining for 
Med22 in adult human kidney shows strong signal in glomeruli (G) and only sparse reactivity outside glomeruli. 
(C) Double labelling experiments with vimentin (red) shows partial co-localization (yellow) in podocyte major 
processes. No significant overlapping reactivity is observed with foot process marker nephrin (red), mesangial 
marker alpha-smooth muscle actin (ASMA, red) or endothelial marker CD31 (red).
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Figure 2.  Generation and characterization of podocyte-specific Med22 mouse line. (A) A mouse line carrying a 
cassette with lacZ and neomycin-resistance genes, as well as FRT and LoxP sites targeting the exon 3 of the Med22 
gene, was crossed with ThIRES-Cre line to generate a conventional knockout allele, and with a FLP-deleter line to 
generate a conditional knockout allele. Floxed mouse line was crossed with a NPHS2-cre line to generate podocyte-
specific knockout line. (B) Genotyping of conditional allele generated a 580 bp product, whereas wild type produced 
a 479 bp band. (C) In control mice, Med22 mRNA spanning exon 2–4 and exon 1–2 were amplified in glomerular, 
lung and spleen tissue. In pod-Med22 mice, the same products were amplified but also an additional shorter variant 
in glomerular tissue was detected with primers targeting exons 2 and 4. This corresponded in size to the skipping of 
exon 3. (D) No significant albuminuria is detected in pod-Med22 mice at 8 weeks of age as detected by measuring 
urine albumin/creatinine ratios. At 12 weeks, pod-Med22 mice show massive albuminuria that further progresses 
by 16 weeks of age. Blood urea nitrogen levels were unchanged in pod-Med22 mice at 8 weeks of age but were 
significantly elevated at 16 weeks of age. Pod-Med22 mice start to die prematurely at 15 weeks of age and no mice 
survive past 20 weeks. ns not significant, **p < 0.01, ***p < 0.001.
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Figure 3.  Histological analysis of pod-Med22 mice show formation of vesicular structures in podocytes 
followed by development of glomerulosclerosis. (A) No histological abnormalities are detected in 8-week old 
mice as shown by PAS staining. (B) At 12 weeks, numerous glomerular and tubulointerstitial abnormalities 
are detected. In glomeruli, focal segmental sclerosis (arrow) is detected and large vesicular structures (*) are 
observed. Tubuli show hyaline casts and dilation, and interstitial fibrosis is observed. (C) At 16 weeks of age, 
most glomeruli are completely sclerotic. Tubuli show more pronounced dilation and hyaline casts. (D) Semi-
quantification of histological changes in pod-Med22 mice versus littermate control mice. There is a significant 
increase in a proportion of abnormal glomeruli, the presence of glomerular vacuoles and tubular casts at both 12 
and 16 weeks of age. G glomerulus; TC tubular casts. ***p < 0.001.
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Figure 4.  Electron microscopy of pod-Med22 kidneys shows progressive vesicular lesions in podocytes. (A) 
At 8 weeks, pod-Med22 mice show podocyte foot process effacement as validated by calculating number of slits 
per GBM length. (B) At 12 weeks, vesicular structures (*) are regularly detected in podocyte (P) cytoplasm. 
Occasionally, the vesicles are obstructing podocyte nuclei. Vesicular membranes (VM) lack electron-dense 
surface that is present on plasma membrane (PM) of podocytes. (C) At 16 weeks of age, glomeruli show areas of 
GBM that are not covered by podocytes (arrowheads) indicating podocyte loss. Moreover, completely sclerotic 
glomeruli are detected. US urinary space; CL capillary lumen; fp foot process. *p < 0.05.
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in 8-week old pod-Med22 mice (data not shown). At 12 weeks of age, round vacuoles were regularly observed 
inside podocytes (Fig. 4B). These vacuoles showed a single simple membrane, which lacked the electron-dense 
glycocalyx that was detectable on podocyte plasma membrane (Fig. 4B). Vacuoles showed occasionally hetero-
geneous electron density, which was in contrast to urinary space that demonstrated mostly clear homogenous 
signal. Occasionally, podocytes showed nuclear changes suggesting an apoptotic process (Fig. 4B). At 16 weeks 
of age, sclerotic regions in glomeruli and occasionally areas of the glomerular basement membrane (GBM) that 
were not covered by podocytes were detected (Fig. 4B), suggesting the loss of podocytes.
As vacuole-like structures reminded of a sub-podocyte  space3,12, we performed a high-resolution microscopy 
and detailed electron microscopic analysis to see whether these structures had connections to Bowman’s space. 
In pod-Med22 podocytes carrying a tomato-reporter, we detected spherical structures that were surrounded 
by cytoplasmic (Suppl. Media 1 and 2). A detailed visual evaluation of these structures showed that only 12 out 
of 77 vacuoles (16%) showed a suspected connection to Bowman’s space (Suppl. Media 1 and 2). In electron 
microscopy, the analysis of vacuole-like structures in 40 pod-Med22 glomeruli (aged 12–16 weeks) showed no 
connections to Bowman’s space (data not shown). Taken together, morphological analysis showed that pod-
Med22 mice develop intracellular vacuoles in podocytes followed by loss of podocytes.
Immunofluorescence analysis of pod‑Med22 podocytes. To analyse podocytes in more detail, we 
stained for podocyte markers nephrin, synaptopodin and WT1. All markers showed progressive loss of signal 
starting at 8 weeks and by 16 weeks only few glomeruli showed positivity (Fig. 5A). The quantification of WT1 
nuclei showed a clear reduction at both 12 and 16 weeks. The results are in line with our morphological data that 
suggest dedifferentiation followed by loss of podocytes.
To investigate the molecular nature of podocyte vacuoles, we performed immunofluorescence staining for 
vesicular markers. Lysosomal marker LAMP2 was upregulated in 12-week old glomeruli and localized mainly to 
podocytes as shown by double-labelling with WT1 and CD31 (Fig. 5B). Of note, LAMP2 was not up-regulated 
in 8-week old pod-Med22 glomeruli (data not shown). Endocytosis marker caveolin was also upregulated in 
podocytes at 12 weeks as caveolin co-localized with LAMP2 (Fig. 5B). Neither endosomal marker clathrin nor 
early endocytosis marker Rab5 were changed in comparison to controls (Fig. 5B). Moreover, no difference in 
autophagy markers beclin, Atg16L, Atg5 and LC3A/B was detected by immunofluorescence or Western blot 
(data not shown).
RNAseq of KO glomeruli unravels downregulation of podocyte genes. To get molecular insights 
into the process in pod-Med22 glomeruli, we performed RNA sequencing (RNAseq) on glomeruli isolated from 
8-week old mice. The sequencing revealed 126 significantly differentially expressed genes of which 78 were up- 
and 48 downregulated (Suppl. Table 1). There was a down-regulation of podocyte genes, which was in line with 
our immunofluorescence data. Besides downregulation of Rab3b, no vesicle transport genes were differentially 
expressed.
Pod‑Med22 mice are susceptible to kidney damage. As pod-Med22 animals did not show any renal 
phenotype during the first 8 weeks of life, we wanted to analyse whether a Med22-defect in podocytes modulated 
disease progression during this period. We induced glomerulonephritis at 4 weeks of age using a nephrotoxic 
serum that binds to the GBM. Both pod-Med22 and litter-mate controls developed similar albuminuria within 
48 h after the induction (Fig. 6A). No significant difference in BUN levels were detected (Fig. 6B). However, in 
histological examination we detected a significant difference as pod-Med22 mice developed more glomerular 
damage as indicated by scoring of sclerotic changes (Fig. 6C,D). Additionally, more tubular casts were detected 
in pod-Med22 kidneys (Fig. 6C,D).
Discussion
We identified mediator complex protein Med22 as a podocyte-enriched molecule and show that although Med22 
is not needed for normal podocyte development, it plays a critical role in the maintenance of glomerular filtration 
barrier as mice with a mutant Med22 in podocytes develop a progressive renal disease. Our study shows for the 
first time that the mediator complex has a critical role in kidney biology.
So far, only few studies have focused on Med22. It was originally termed as Surf5, due to its location in Sur-
feit locus in mouse  genome13, and later identified to be a component of the mediator complex, and possibly to 
directly interact with  Med3014. Interestingly, studies in cell culture suggested that Med22 protein is localized in 
the  cytoplasm15. Our immunofluorescence studies support this notion as we detected the Med22 protein mainly 
in the cytoplasm of podocytes. This was somewhat surprising taking into account the role of MED in transcrip-
tion. It may be that Med22 shuttles between the cytoplasm and the nucleus, similar to MED subunit 28, which has 
been suggested to have dual functions in these  compartments16,17. Due to lack of Med22 expression in podocyte 
cell culture models, we did not investigate this further.
Med22-deficiency in mouse podocytes resulted in renal failure and premature death by 20 weeks of age. Start-
ing around 8 weeks-of-age mice developed intracellular vacuoles, which was followed by podocyte death. The 
exact mechanism how these vesicles lead to podocyte death is unclear, but our temporal morphological analysis 
showed that the vesicles grew dramatically in size and finally occupied almost the whole cytoplasm displacing 
nuclei and other intracellular structures. This can result in general cellular dysfunction and cell death.
Mediator is a multi-protein complex that is essential for gene transcription via RNA polymerase  II8,18. So 
far, all KO mouse models generated for mediator subunits have been embryonic lethal suggesting that mediator 
action is critical for embryonic  development8,18. Our study supports this notion as embryos homozygous for 
constitutive Med22 allele die in utero. Embryonic lethality has hampered in vivo studies on mediator complex. 
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Figure 5.  Immunofluorescence analysis of podocytes in pod-Med22 mice. (A) Expression of podocyte proteins 
nephrin, synaptopodin and WT1 progressively decreases in pod-Med22 glomeruli. At 8-weeks, staining for 
podocyte markers is similar to control animals. In 12-week old mice, the signal is clearly decreased and at 
16-weeks, nephrin and WT1 staining is rarely detected and only occasionally reactivity for synaptopodin is 
observed. Quantification of WT1 positive nuclei per glomerulus validates the loss of podocytes. (B) In pod-
Med22 mice, strong up-regulation of LAMP2 is detected in WT1-positive cells. Double labelling with CD31 
shows that LAMP2 is located on the urinary side of CD31 staining and no overlapping reactivity is detected. 
Immunoreactivity for caveolin is clearly increased in LAMP2 positive cells in pod-Med22 glomeruli. Clathrin 
and Rab5 do not show any differential expression in pod-Med22 glomeruli. ***p < 0.001.
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Figure 6.  Pod-Med22 podocytes are sensitive to stress and respond by vesicle formation. (A) After induction 
of glomerular injury by nephrotoxic serum, both pod-Med22 and control mice develop massive albuminuria 
and no significant difference is detected between the groups. (B,C) In histological analysis 14 days after the 
induction of glomerulonephritis, significantly more sclerotic lesions were detected in pod-Med22 mice. 
Similarly, significantly more tubular casts are detected in pod-Med22 mice. G glomerulus; TC tubular cast. ns 
not significant, **p < 0.01, ***p < 0.001.
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To overcome this, we inactivated Med22 specifically in podocytes and saw that although Med22 was highly 
expressed by these cells, it was not essential for the development or initial maintenance of podocyte structure 
and function. There are several potential explanations for this. It is possible that Med22-dependent biological 
processes become active later in life. In fact, although the glomerulus seems to be structurally mature 2 weeks 
after birth in mouse, we have observed significant expressional differences in isolated glomeruli at later stages of 
life (unpublished data). On the other hand, it is possible that Med22 allele generated is not a null but a hypomor-
phic allele and this function could be sufficient for normal podocyte development. However, we speculate that 
the “late” phenotype may be a result of the accumulation of damage. Minor defects in transcriptional machinery 
may exist already at birth but these can fall under our detection threshold. This idea is supported by our data in 
4-week-old pod-Med22 mice that were prone to develop podocyte damage and developed vacuole-like structures 
under pathological stimuli.
We made an effort through RNAseq and immunostaining to pinpoint molecular mechanisms that drive the 
disease development in pod-Med22 mice. However, we failed to identify a clear pathway that would be respon-
sible for the phenotype. It may be that Med22 mediates transcription of multiple pathways that are difficult to 
define through molecular profiling. Thus, it is difficult to say whether Med22-mediated pathways contribute to 
the pathogenesis of human glomerular diseases. Vacuole-like structures in podocytes, reminding of the pheno-
type in our pod-Med22 mice, have been reported in common human  glomerulopathies19,20, and therefore, it is 
possible that Med22 has a role even in human glomerulopathies. Obviously, more studies are needed to dissect 
the role of Med22 in podocytes, as well as to understand how mediator complex contributes to kidney biology.
Materials and methods
RT‑PCR. Glomeruli were isolated from human and mouse kidneys as published  previously21,22. RT-PCR 
experiments were performed using standard methods. Primer sequences for Med22 were: Human 5′-GTT GGG 
GAT CTC AGC AGT GG-3′, 5′-CAG CCC ATG GCA CAG ACA TA-3′. For the amplification of mouse exons, 
we used: Med22Ex1-2 CAG CCC TCA GTA CTC GGT TC (left), Med22Ex1-2 GCT CGA ACG TGC ATC TCA 
TA (right), Med22 Ex2-4 AGG TGT CTC GGG CTA CTC AG (left), Med22Ex2-4 TAA GGG ACC AGC ACC 
AGT CT (right).
Immunofluorescence. Normal human adult kidney samples were collected from kidneys nephrectomised 
due to renal cancer (Karolinska University Hospital, Stockholm, Sweden). Nephrin and podocin antibodies have 
been described  previously9,23. Other antibodies were: Med22—Atlas Antibodies and Sigma; Vimentin, alpha 
SMA, WT-1—Sigma (human); CD31—Abcam; Clathrin, Caveolin, Lc3II, Atg16L, Atg5, Beclin, Rab5, Rab7, 
Rab11 (Cell Signalling); Synaptopodin, Rab3b and LAMP2 (Santa Cruz), mouse nephrin (Acris), mouse WT1 
(Millipore).
The samples were snap-frozen, and the cryosections (10 μm) were post-fixed with cold acetone (− 20 °C) 
followed by blocking in 5% normal goat serum. The primary antibodies were incubated overnight at 4 °C, fol-
lowed by a 1-h incubation with the secondary antibody. For double-labelling experiments, the incubations were 
performed sequentially.
Generation of Med22 knockout mouse lines. We used a line generated by European Mouse Mutant 
Cell Repository in which the cassette containing lacZ, neomycin-resistance gene, and FRT and LoxP sites were 
targeted to exon 3 of Med22 gene. The mice were in a mixed C57bl/6 129 Sv background. We crossed these mice 
with Th-IRES  deleter10, as well as with a FLP-deleter line (B6.129S4-Gt(ROSA)26Sortm1(FLP1)Dym/RainJ) to 
generate a floxed mouse line for Med22 gene (Med22-fl). Med22-fl was crossed Tg-Nphs2-cre11 to inactivate 
Med22 specifically in podocytes (pod-Med22).
Histological analyses. Histological analyses were done using PAS (Periodic Acid-Schiff) staining. For 
16-week-old mice, 8 controls and 8 knockout animals were analysed. For 12-week-old, 17 controls and 7 knock-
out animals were analysed. For 8-weeks-old, 7 controls and 6 knockout animals were analysed. For 1-year-old 
Med22 global heterozygous 4 controls and 7 heterozygous mice were analysed at 15 months. Glomerular dam-
age was evaluated by semi-quantitative scoring of histological changes. Glomeruli were scored as having normal 
histology or abnormal histology (which was usually associated with the presence of sclerosis/mesangial matrix 
expansion/crescents). The presence of detectable vacuole-like structures in each glomeruli was evaluated and 
scored separately. We evaluated 30 random glomeruli in each mouse. For the analysis of tubular changes, we 
chose 10 random high power filed (× 40) images from renal cortex and observed the presence of tubular casts.
Electron microscopic analysis were with standard transmission microscopy using samples fixed with 2.5% 
glutaraldehyde. Especially, we focused on podocytes and vesicular structures in podocytes. A total of 40 vesicular 
structures in 12 and 16-week old pod-Med22 mice were analysed and categorized as having a connection to 
Bowman’s space or being isolated vesicle without detectable connection to extracellular space.
Tissue expansion and analysis of expanded kidney samples. Kidney samples were expanded as 
described  previously24. Samples were then stained for tdTomato using a goat anti-tdTomato antibody (Sigma 
AB8181-200) and a donkey anti-goat Alexa-488 secondary antibody. Samples were then imaged on a Zeiss 
LSM780 inverted confocal microscope using a 40X NA1.3 water immersion objective.
Every large vesicle in podocytes (exceeding 1 µm in depth) was categorized into three groups; open, closed 
or non-conclusive. Only vesicles that were completely surrounded by tdTomato signal were marked as closed. 
The vesicles that could not be completely excluded to have an opening to extracellular space were marked as 
non-conclusive. The vesicles with an apparent opening to extracellular space were marked as open.
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Urine analysis. Albuminuria was analysed by running 2 µl of urine on SDS-PAGE gel stained with PAGE-
Blue stain (Invitrogen) or/and by calculating urinary albumin/creatinine ratios (Exocell Albuwell kit, Bioas-
say kit). Following animals were analysed: For 16-week-old mice 6 littermates and 5 pod-Med22 animals; For 
12-week-old mice 14 littermates and 7 pod-Med22 animals; For 8-week-old mice 7 littermate and 6 pod-Med22 
animals; For 4-week-old mice 5 littermates and 5 pod-Med22 animals.
Blood analysis. Blood-urea-nitrogen (BUN) values were determined using ELISA kit from Abcam. Fol-
lowing mice were analysed: 5 pod-Med22 and littermate control animals at 16-weeks of age, 6 pod-Med22 and 
9 littermate control animals at 8 weeks of age, as well as 5 pod-Med22 and 5 littermate control animals treated 
with nephrotoxic serum (see below).
Bulk RNA sequencing. RNA sequencing was performed for glomeruli isolated from 3 pod-Med22 and 3 
littermate control mice at 8-weeks of age. Total RNA was isolated using a combination of Trizol and Chloroform 
extraction and Qiagen RNAeasy clean-up columns. Total RNA quality and concentration were measured by 
Agilent BioAnalyzer 2100. All samples passed quality criteria RIN > 8.0, 28S/18S > 1.0. RNA samples were then 
prepared and sequenced by commercial service in BGI tech.
100 bp pair-end reads (pure reads without adapters) were received from BGI tech. More than 22 million 
reads passed quality control (quality score > 28) for each sample. Qualified reads were mapped to mouse refer-
ence genome Ensembl GRCm38 and transcriptome gene guild version 89 with alignment tool STAR 2.5.2b25. 
Uniquely mapped reads were then quantified as counts by FeatureCount v1.5.1. Differentially expressed genes 
were tested by R package  DESeq226. Only genes with significance FDR < 0.05 (False Discovery Rate) are reported.
Anti‑GBM glomerulonephritis model. The induction of glomerulonephritis using anti-glomerular 
serum (Probetex, cat: PTX-001S) was performed as recently  described27. A total of 10 4-week old animals (5 
pod-Med22 and 5 controls) were used.
Glomerular damage was evaluated by semi-quantitative scoring of histological changes. Glomeruli were 
scored as having normal histology or abnormal histology (which was usually associated with the presence of 
sclerosis/mesangial matrix expansion/crescents). We evaluated 30 random glomeruli in each mouse (5 control 
and 5 pod-Med22 mice). For the analysis of tubular changes, we chose 10 random high power filed (× 40) images 
from renal cortex and observed the presence of tubular casts.
Statistical methods. We used Prism statistics program: Student T test parametric (even groups) and non-
parametric (non-even groups). Minimum for significance was p < 0.05, in the figures p values are indicated as 
follows: *p < 0.05, **p < 0.01, ***p < 0.001.
Ethical considerations. The use of human material for studies was approved by the local Ethics Review 
Authority (“Etikprövningsmyndighet”, www.epn.se) in Stockholm, Sweden, archive number 2017-58-31/4. 
Informed consent was obtained from all subjects. All methods used in human material were carried out in 
accordance with relevant guidelines and regulations defined in the ethical permit (see above).
For mouse work, all experimental protocols were approved by The Linköping Ethical Committee for Research 
Animals (“Linköpings djurförsöksetiska nämnd”), Linköping, Sweden (archive number DNR 41-15). All methods 
used in mouse experiments were carried out in accordance with relevant guidelines and regulations defined in 
the ethical permit (see above).
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